Kidney Cancer Canada
Kidney Cancer Canada is a patient-led support organization established to improve the quality of life for patients and their families living with kidney cancer. Kidney Cancer Canada advocates for access to new treatments, provides support and information to patients, and works to increase awareness of kidney cancer as a significant health issue. Their goal is to help patients navigate through information about their disease and ensure they have access to new treatment options available to them.
During 2015, GSK funded Kidney Cancer Canada with $22,500 in core funding.
GSK’s contributions represent 2.8% of the organization’s total revenue in 2015.